Comparative Bioavailability Study of Lamotrigine ER Tablets USP 50 mg
Clinical trial NCT05145608 · COMPLETED
Trial details
- NCT number
- NCT05145608
- Sponsor
- Alembic Pharmaceuticals Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-01-10
- Primary completion
- 2018-02-21
- Enrollment
- 22
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.